Key result
Adipose tissue-derived exosomes may play an essential role in the development of insulin resistance and metabolic disorders.
This review highlights the potential role of adipose tissue-derived exosomes in the pathogenesis of insulin resistance and metabolic disorders.
Answers are grounded in this paper and cite their sources.
Obesity may disrupt beneficial adipose signaling in cardiometabolic care; leaves open exosome-targeted therapies pending prospective validation.
Adipose tissue (AT) is an endocrine organ involved in the management of energy metabolism via secretion of adipokines, hormones, and recently described secretory microvesicles, i.e., exosomes. Exosomes are rich in possible biologically active factors such as proteins, lipids, and RNA. The secretory function of adipose tissue is affected by pathological processes. One of the most important of these is obesity, which triggers adipose tissue inflammation and adversely affects the release of beneficial adipokines. Both processes may lead to further AT dysfunction, contributing to changes in whole-body metabolism and, subsequently, to insulin resistance. According to recent data, changes within the production, release, and content of exosomes produced by AT may be essential to understand the role of adipose tissue in the development of metabolic disorders. In this review, we summarize actual knowledge about the possible role of AT-derived exosomes in the development of insulin resistance, highlighting methodological challenges and potential gains resulting from exosome studies.
No takes yet. Share an insight, caveat, or question.
Żbikowski et al. (2021) conducted a review in Insulin resistance. Adipose-derived exosomes was evaluated. Adipose tissue-derived exosomes may play an essential role in the development of insulin resistance and metabolic disorders.
Synapse has enriched 10 related papers. Consider them for comparative context: